Orkla Health has appointed BioGaia’s Isabelle Ducellier as its CEO. Expected to take up her new position in the fourth quarter of 2023, Ducellier will succeed Hege Holter Brekke, who has been promoted to the role of EVP & investment executive at parent company Orkla ASA.
CEO and president of BioGaia since November 2018 – a role she will continue to hold until 30 September 2023 – Ducellier brings to Norway’s Orkla Health “extensive business experience from the consumer